World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with coronavirus disease 2019 (Covid-19).
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results
Tacconelli, Evelina;
2021-01-01
Abstract
World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with coronavirus disease 2019 (Covid-19).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
THE NEW ENGLAND JOURNAL OF MEDICINE 2021.pdf
solo utenti autorizzati
Tipologia:
Versione dell'editore
Licenza:
Copyright dell'editore
Dimensione
715.87 kB
Formato
Adobe PDF
|
715.87 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
